Page 4 - Sister Study News Today

Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners may pose cancer and other health risks.

Social and economic pressures have long compelled Black girls and women to straighten their hair to conform to Eurocentric beauty standards. But chemical...

Social and economic pressures have long compelled Black girls and women to straighten their hair to conform to Eurocentric beauty standards. But chemical straighteners are stinky and costly and sometimes cause painful scalp burns. Mounting evidence now shows they could be a health hazard.

Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners — products with little regulatory oversight — may pose cancer and other health risks.

Receiving a diagnosis of breast cancer and radiation treatment were both associated with increased rates of biological aging among patients who participated in a recent study.

Hair dyes, straighteners/relaxers, and permanents/body waves may increase the risk of breast and gynecologic cancers.

Women who have survived breast cancer age faster than women who have never had to survive the disease.

Women diagnosed and treated for breast cancer have increased biological aging compared to women who remain free of breast cancer, according to a new study by researchers at the National Institutes of Health and their collaborators.

“Of the three treatment classes we looked at, radiation therapy had the strongest associations with the biologic age measures assessed in the study,” said Jack Taylor, M.D., Ph.D., the senior author of the paper who is an Emeritus Scientist at NIEHS. “The increases can be detected years after treatment.” Women Who Underwent Breast Cancer Treatment Age Faster, Reveals Study.

Recent estimates indicate that Nigeria loses more than N10.8 billion to treat about 12.77 million women of reproductive age that develop uterine fibroids, at a cost of about N850,000 per patient